Tagged Thyroid Cancer

Oral lenvatinib exhibited with five-fold improvement in progression-free treatment of thyroid cancer

Oral lenvatinib exhibited with five-fold improvement in progression-free treatment of thyroid cancer

Feb 14, 2015

A recent study shows that oral lenvatinib shows increased delay in the progression of advanced thyroid cancer as compared to placebo treatment. While the former exhibited results showing 18 months of delayed pr...

Researchers develop new drug Lenvatinib that can slow progression of Thyroid Cancer

Ally Stackhouse

Feb 13, 2015

A new thyroid cancer drug can slow the progression of the disease almost five times as compared to placebo in a new clinical trial. The new molecule, lenvatinib is a targeted therapy which deters the formation ...